immunotherapy
Advertisement
Checkpoint Therapeutics has added Amit Sharma, MD, to its board.
Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...
Adoptive immunotherapy with CD4+/CD25/+FOXP3+ regulatory T cells (Tregs) and conventional T cells (Tcons) has been used ...
Is a vaccine for multiple myeloma feasible? DocWire News spoke with Nikhil Munshi, MD, Professor at Harvard Medical ...
A study published in The Laryngoscope assessed different treatment modalities for patients with sinonasal diffuse large ...
On April 16, the U.S. Food and Drug Administration (FDA) approved nivolumab in combination with fluoropyrimidine- and ...
This week, findings from a clinical trial of children with high-risk Hodgkin lymphoma found the anti-CD30 antibody drug ...
A retrospective study found that patients with preexisting autoimmune diseases (PADs) may experience exacerbations ...
Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy
...
A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to ...
Researchers from the biotherapeutics company Carina Biotech and the University of South Australia have developed a ...
A study published in Clinical Cancer Research found that baseline levels of circulating tumor DNA (ctDNA) successfully ...
Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...
Results from “COMBAT Trial” show pancreatic cancer patients can greatly benefit from immunotherapy. The results were ...
Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...
Immunotherapy doesn't worsen complications for patients with both COVID-19 and cancer, according to a preliminary study ...
The findings of a new phase II trial show that the combination of radiation therapy and immunotherapy resulted in ...
Researchers have discovered a new way to improve immunotherapy by using genomics to inform immunotherapy treatments for ...
A study published in JAMA Oncology assessed the tolerability of sequential immunotherapy following chemoradiotherapy ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.